By: IPP Bureau
Last updated : December 16, 2025 11:32 am
This launch is part of the company's strategy to expand its nutraceutical portfolio
Shelter Pharma has expanded its nutraceutical portfolio with the launch of D3 Cure Capsules tapping into rapidly growing international market. Primary benefit is the prevention and treatment of vitamin D deficiency. It plays a crucial role in helping the body absorb calcium and phosphorus, which are essential for maintaining overall health.
This launch is part of the company's strategy to expand its nutraceutical portfolio and strengthen its presence in the wellness and preventive healthcare segment.
Shelter believes that the launch of this product will contribute positively to its growth prospects and reinforce its commitment to providing high-quality, sciencebacked nutritional solutions.